Racial/ethnic disparities in measure calculations for Part D Star Ratings among Medicare beneficiaries with diabetes, hypertension, and/or hyperlipidemia.

[1]  Haiqun Lin,et al.  Validity of Race and Ethnicity Codes in Medicare Administrative Data Compared With Gold-standard Self-reported Race Collected During Routine Home Health Care Visits , 2019, Medical care.

[2]  V. Mor,et al.  Medicare Advantage Ratings And Voluntary Disenrollment Among Patients With End-Stage Renal Disease. , 2018, Health affairs.

[3]  P. Heaton,et al.  Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System , 2016, Journal of managed care & specialty pharmacy.

[4]  B. Patel,et al.  Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures? , 2016, Journal of managed care & specialty pharmacy.

[5]  Pengxiang Li,et al.  Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment before and after Implementation of Quality-Related Bonus Payments in 2012 , 2016, PloS one.

[6]  S. Seabury,et al.  Medication adherence and measures of health plan quality. , 2015, The American journal of managed care.

[7]  J. Xu,et al.  Does Good Medication Adherence Really Save Payers Money? , 2015, Medical care.

[8]  J. Couto,et al.  Geographic Variation in Medication Adherence in Commercial and Medicare Part D Populations , 2014, Journal of managed care & specialty pharmacy.

[9]  J. Bentley,et al.  Measuring Pharmacy Performance in the Area of Medication Adherence: Addressing the Issue of Risk Adjustment , 2014, Journal of managed care & specialty pharmacy.

[10]  J. Steiner,et al.  Medicare Star excludes diabetes patients with poor CVD risk factor control. , 2014, The American journal of managed care.

[11]  G. Young,et al.  Socioeconomic characteristics of enrollees appear to influence performance scores for medicare part D contractors. , 2014, Health affairs.

[12]  T. Brennan,et al.  Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes. , 2014, American heart journal.

[13]  P. Rosenberg,et al.  Pharmacotherapeutic Management of Dementia Across Settings of Care , 2013, Journal of the American Geriatrics Society.

[14]  B. Stuart,et al.  Use and Spending on Antineoplastic Therapy for Medicare Beneficiaries With Cancer , 2013, Medical care.

[15]  B. Zarowitz,et al.  Focus on Medicare's 5-Star plan ratings for prescription drug plans. , 2013, Geriatric nursing.

[16]  P. Deb,et al.  Association between Medicare Advantage plan star ratings and enrollment. , 2013, JAMA.

[17]  A. Jha,et al.  Greater adherence to diabetes drugs is linked to less hospital use and could save nearly $5 billion annually. , 2012, Health affairs.

[18]  Bruce G. Link,et al.  Social Conditions as Fundamental Causes of Health Inequalities: Theory, Evidence, and Policy Implications , 2010, Journal of health and social behavior.

[19]  J. Gurwitz,et al.  Patients At-Risk for Cost-Related Medication Nonadherence: A Review of the Literature , 2007, Journal of General Internal Medicine.

[20]  J. Doshi,et al.  Medicare beneficiaries and the impact of gaining prescription drug coverage on inpatient and physician spending. , 2005, Health services research.

[21]  Hsou-Mei Hu,et al.  National examination of compliance predictors and the immunization status of children: precursor to a developmental model for health systems. , 2004, Military medicine.

[22]  J. Escarce,et al.  Racial and ethnic differences in public and private medical care expenditures among aged Medicare beneficiaries. , 2003, The Milbank quarterly.

[23]  R. Andersen,et al.  The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. , 2000, Health services research.

[24]  N. Col,et al.  The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. , 1990, Archives of internal medicine.